Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Acta Neuropathologica|January 6, 2024
CSF p-tau205: a biomarker of tau pathology in Alzheimer's diseaseJuan Lantero-Rodriguez, Laia Montoliu-Gaya, Andrea L Benedet, et al.
Medrxiv : the Preprint Server for Health Sciences|October 24, 2023
A novel ultrasensitive assay for plasma p-tau217: performance in individuals with subjective cognitive decline and early Alzheimer's diseaseFernando Gonzalez-Ortiz, Pamela C L Ferreira, Armand Gonzalez, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 17, 2023
A novel ultrasensitive assay for plasma p-tau217: Performance in individuals with subjective cognitive decline and early Alzheimer's diseaseFernando Gonzalez-Ortiz, Pamela C L Ferreira, Armand González-Escalante, et al.
Neurology|September 24, 2021
CSF Synaptic Biomarkers in the Preclinical Stage of Alzheimer Disease and Their Association With MRI and PET: A Cross-sectional StudyMarta Milà-Alomà, Ann Brinkmalm, Nicholas J Ashton, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 10, 2025
Cerebrospinal fluid and brain positron emission tomography measures of synaptic vesicle glycoprotein 2A: Biomarkers of synaptic density in Alzheimer's diseaseAdam P Mecca, Nicholas J Ashton, Ming-Kai Chen, et al.
Nature Medicine|February 10, 2025
Phospho-tau serine-262 and serine-356 as biomarkers of pre-tangle soluble tau assemblies in Alzheimer's diseaseTohidul Islam, Emily Hill, Eric E Abrahamson, et al.
Medrxiv : the Preprint Server for Health Sciences|January 3, 2024
Plasma p-tau212: antemortem diagnostic performance and prediction of autopsy verification of Alzheimer's disease neuropathologyPrzemysław R Kac, Fernando González-Ortiz, Andreja Emeršič, et al.
Nature Communications|March 24, 2024
Plasma p-tau212 antemortem diagnostic performance and prediction of autopsy verification of Alzheimer's disease neuropathologyPrzemysław R Kac, Fernando González-Ortiz, Andreja Emeršič, et al.
Molecular Psychiatry|July 11, 2020
Patient-specific Alzheimer-like pathology in trisomy 21 cerebral organoids reveals BACE2 as a gene dose-sensitive AD suppressor in human brainIvan Alić, Pollyanna A Goh, Aoife Murray, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 18, 2023
Association of plasma biomarkers with cognition, cognitive decline, and daily function across and within neurodegenerative diseases: Results from the Ontario Neurodegenerative Disease Research InitiativeErlan Sanchez, Tim Wilkinson, Gillian Coughlan, et al.
Pageof 6